BACKGROUND: Acquired and inherited bleeding disorders may present in the neonatal period with devastating lifelong effects. Diagnosing bleeding disorders in the neonatal population could aid in preventing and treating the associated complications. However, currently available platelet function testing is limited in neonates, owing to difficulties in obtaining an adequate blood volume, a lack of normal reference ranges, and an incomplete understanding of the neonatal platelet functional phenotype. OBJECTIVE: To develop small-volume, whole blood platelet function assays in order to quantify and compare neonatal and adult platelet function. METHODS AND RESULTS: Peripheral blood was obtained from healthy, full-term neonates at 24 h of life. Platelet activation, secretion and aggregation were measured via flow cytometry. Platelet adhesion and aggregation were assessed under static and flow conditions. As compared with adult platelets, peripheral neonatal platelet P-selectin expression and integrin glycoprotein IIbIIIa activation were significantly reduced in response to the G-protein-coupled receptor (GPCR) agonists thrombin receptor activator peptide-6 (TRAP-6), ADP, and U46619, and the immunoreceptor tyrosine-based activation motif (ITAM) signaling pathway agonists collagen-related peptide (CRP) and rhodocytin. Neonatal platelet aggregation was markedly reduced in response to TRAP-6, ADP, U46619, CRP and rhodocytin as compared with adult platelets. The extents of neonatal and adult platelet adhesion and aggregate formation under static and shear conditions on collagen and von Willebrand factor were similar. CONCLUSIONS: As compared with adult platelets, we found that neonatal platelet activation and secretion were blunted in response to GPCR or ITAM agonists, whereas the extent of neonatal platelet adhesion and aggregate formation was similar to that of adult platelets.
BACKGROUND: Acquired and inherited bleeding disorders may present in the neonatal period with devastating lifelong effects. Diagnosing bleeding disorders in the neonatal population could aid in preventing and treating the associated complications. However, currently available platelet function testing is limited in neonates, owing to difficulties in obtaining an adequate blood volume, a lack of normal reference ranges, and an incomplete understanding of the neonatal platelet functional phenotype. OBJECTIVE: To develop small-volume, whole blood platelet function assays in order to quantify and compare neonatal and adult platelet function. METHODS AND RESULTS: Peripheral blood was obtained from healthy, full-term neonates at 24 h of life. Platelet activation, secretion and aggregation were measured via flow cytometry. Platelet adhesion and aggregation were assessed under static and flow conditions. As compared with adult platelets, peripheral neonatal platelet P-selectin expression and integrin glycoprotein IIbIIIa activation were significantly reduced in response to the G-protein-coupled receptor (GPCR) agonists thrombin receptor activator peptide-6 (TRAP-6), ADP, and U46619, and the immunoreceptor tyrosine-based activation motif (ITAM) signaling pathway agonists collagen-related peptide (CRP) and rhodocytin. Neonatal platelet aggregation was markedly reduced in response to TRAP-6, ADP, U46619, CRP and rhodocytin as compared with adult platelets. The extents of neonatal and adult platelet adhesion and aggregate formation under static and shear conditions on collagen and von Willebrand factor were similar. CONCLUSIONS: As compared with adult platelets, we found that neonatal platelet activation and secretion were blunted in response to GPCR or ITAM agonists, whereas the extent of neonatal platelet adhesion and aggregate formation was similar to that of adult platelets.
Authors: Denisa Urban; Fred G Pluthero; Hilary Christensen; Shoma Baidya; Margaret L Rand; Animitra Das; Prakeshkumar S Shah; David Chitayat; Victor S Blanchette; Walter H A Kahr Journal: Haematologica Date: 2016-11-03 Impact factor: 9.941
Authors: Anh T P Ngo; Jawaad Sheriff; Anne D Rocheleau; Matthew Bucher; Kendra R Jones; Anna-Liisa I Sepp; Lisa E Malone; Amanda Zigomalas; Alina Maloyan; Wadie F Bahou; Danny Bluestein; Owen J T McCarty; Kristina M Haley Journal: Platelets Date: 2019-02-27 Impact factor: 3.862
Authors: Jevgenia Zilberman-Rudenko; Frank Z Zhao; Stephanie E Reitsma; Annachiara Mitrugno; Jiaqing Pang; Joseph J Shatzel; Beth Rick; Christina Tyrrell; Wohaib Hasan; Owen J T McCarty; Martin A Schreiber Journal: Cardiovasc Eng Technol Date: 2018-05-21 Impact factor: 2.495
Authors: Jevgenia Zilberman-Rudenko; Joanna L Sylman; Hari H S Lakshmanan; Owen J T McCarty; Jeevan Maddala Journal: Cell Mol Bioeng Date: 2016-10-20 Impact factor: 2.321
Authors: Anne D Rocheleau; Ayesha Khader; Anh T P Ngo; Colin Boehnlein; Cara McDavitt; Susan Lattimore; Michael Recht; Owen J T McCarty; Kristina M Haley Journal: Pediatr Res Date: 2018-01-03 Impact factor: 3.756
Authors: Katrin Herken; Martin Glauner; Stefanie C Robert; Matthias Maas; Sonja Zippel; Ulrike Nowak-Göttl; Barbara Zieger; Judith Lahav; Anke C Fender; Kerstin Jurk; Beate E Kehrel Journal: Int J Mol Sci Date: 2021-05-05 Impact factor: 5.923
Authors: Alexander T Hardy; Verónica Palma-Barqueros; Stephanie K Watson; Jean-Daniel Malcor; Johannes A Eble; Elizabeth E Gardiner; José E Blanco; Rafael Guijarro-Campillo; Juan L Delgado; María L Lozano; Raúl Teruel-Montoya; Vicente Vicente; Steve P Watson; José Rivera; Francisca Ferrer-Marín Journal: Thromb Haemost Date: 2018-04-25 Impact factor: 5.249